Multidisciplinary care in cystic fibrosis; a clinical-nutrition review;Atención multidisciplinaria en la fibrosis quística; una revisión clínica y nutricional

Nutricion Hospitalaria

Volumn 27, Issue 2, 2012, Pages 362-371

  Haack, A ^a   Garbi Novaes, M R ^b  

^a HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^b Primate Center   (Brazil)

Author keywords

Cystic fibrosis; Lung disease; Neonatal screening; Nutritional status; Spirometry

Indexed keywords

SYRINGA;

CYSTIC FIBROSIS; GENETICS; HUMAN; NUTRITION; NUTRITIONAL SUPPORT; PATIENT CARE; PHYSIOTHERAPY; REVIEW;

CYSTIC FIBROSIS; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL SUPPORT; PATIENT CARE TEAM; PHYSICAL THERAPY MODALITIES;

EID: 84858727618     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.2.5442     Document Type: Review

References (77)

1. Milla CE. Nutrition and lung disease in cystic fibrosis. Clin Chest Med 2007; 28 (2): 319-30.
2. Munck A. Nutritional considerations in patients with cystic fibrosis. Expert Rev Med 2010; 4 (1): 47-56.
3. Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, Quittner AL et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cystic Fibros 2010; 9 (1): 1-16.
4. Farrel PM. The prevalence of cystic fibrosis in the European Union. J Cystic Fibros 2008; 7 (5): 450-53.
5. Cystic Fibrosis Foundation. Patient Registry. Annual Data Report to the Center Directors. Bethesda, 2009.
6. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373 (9678): 1891-1904.
7. Honorio LFO, Ludwig Neto N, Barbosa E, Perin N, Gastaldi LA, Ferreri JE, et al. Avaliação da triagem neonatal para fibrose cística no Estado de Santa Catarina. J Bras Pneumol 2006; 32 (1): 1-16.
8. Ribeiro JD, Ribeiro MAGO, Ribeiro A F. Controvérsias na fibrose cística - do pediatra ao especialista. J Pediatrics 2002; 78 (Suppl. 2): 171-186.
9. Adde FV, Silva Filho LVRF, Damaceno N. Fibrose cística. In: Rodrigues JC, Adde F V, Silva Filho LVRF. Pediatria: Doenças Respiratórias. São Paulo: Manole; 2008.
10. Farrel PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008; 153: 4-14.
11. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173: 475-82.
12. Cystic Fibrosis Foundation. Patient Registry. Annual Data Report to the Center Directors. Bethesda, 2006.
13. Mayell SJ, Munck A, Craig JV, Sermet I, Bronlee KG, Schwarz MJ et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009; 8 (1): 71-8.
14. Mall M, Hirtz S, Gonska T, Kunzelmann K. Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis. J Cyst Fibros 2004; 3 (2): 165-169.
15. Gonzales ACS, Vieira SMG, Maurer RL, Silva FAA, Silveira TR. Utilidade da concentração da eslastase-1 fecal monoclonal na avaliação da função pancreática nos pacientes com fibrose cística. J Pediatr 2011; 87 (2): 157-162.
16. Farrel PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001; 107 (1): 1-13.
17. Rosa FR, Dias FG, Nobre LN, Morais HA. Fibrose cística: uma abordagem clinica e nutricional. Revista de Nutrição 2008; 21 (6).
18. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P et al. Pseudomonas cepacia infection in cystic fibrosis: anemerging problem. J Pediatr 1984; 104: 206-10.
19. Evans Ak, Fitzgerald DA, Mckay KO. The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 2001; 18 (5): 784-9.
20. Wood LG, Gibson PG, Garg ML. Circulating markers to assess nutritional therapy in cystic. Clin Chim Acta 2005; 353 (1/2); 13-29.
21. Fiates GMR, Barbosa E, Auler F, Feiten SF, Miranda F. Estado nutricional e ingestão alimentar de pessoas com fibrose cística. Rev Nut 2001; 14 (2): 95-101.
22. Kalivianakis M, Minich DM, Bijleveld CM, Van Aalderen WM, Stellaard F, Lauser M, et al. Fat malabsorption in cystic fibrosis receiving replacement therapy is due to impared intestinal uptake of long chain fatty acids. Am J Clin Nutr 1999; 69 (1): 127-34.
23. Strausbaugh SD, Davis PB. Cystic fibrosis: a review of epidemiology and pathobiology. Clin Chest Med 2007; 28 (2): 279-88.
24. Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH, Haigh I. Osteosporosis and osteopenia em adults and adolescents with cystic fibrosis:prevalence and associated factors. Thorax 2000; 55: 789-804.
25. Sabati AA, Kemainen RR, Milla CE, Ireland M, Schwarzenberg SJ, Dunitz JA, Khan KM. Characteristics of gastroesophageal reflux in adults with cystic fibrosis. J Cystic Fibros 2010; 9 (5): 365-70.
26. Kerem E, Corey M, Kerem B, Durie P, Tsui LC, Levison H. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 1989; 114 (5): 767-73.
27. Van der Doef HPJ, Kokke FJA, Beek FJA, Woestenenk JW, Froeling SP, Houwen RHJ. Constipation in pediatric cystic fibrosis patients: an underestimated medical condition. J Cystic Fibros 2010; 9 (1): 59-63.
28. Shalon LB, Adelson JW. Cystic fibrosis:gastrointestinal complications and gene therapy. Pediatr Clin North Am 1996; 43 (1): 157-96.
29. Moreira RO, Duarte MPC, Farias MLF. Distúrbios do eixo cálcio-PTH-vitamina D nas doenças hepáticas crônicas. Arq Bras End Met 2004; 48 (4): 443-50.
30. Nash KL, Allison ME, McKeon D, Lomas DJ, Haworth CS, Bilton D et al. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cystic Fibros 2008; 7 (3): 252-257.
31. Feijó G, Netto OS, Silva-Neto A V, Zanchet RC, Cunha J. Densidade mineral óssea em fibrocisticos do Distrito Federal. Comum Ciênc Saúde 2006; 17 (2): 87-92.
32. Heron LE, Guillaume C, Velard F, Braux J, Touqui L, Moriceau S et al. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostraglandin (PG) E2 in human bone. Journal of Cystic Fibrosis 2010; 9 (1): 69-72.
33. Olveira G, Olveira C. Nutrition, cystic fibrosis and the digestive tract. Nutr Hosp 2008; 23 (2): 71-86.
34. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G et al. Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes:a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33: 2697-2708.
35. Ripa P, Robertson I, Cowley D, Harris M, Masters IB, Cotterill AM. The relation between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clinical Endocrinology 2002; 56: 383-389.
36. Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004; 3 (4): 209-22.
37. Dorlochter L, Roksund O, Helgheim V, Rosendahl K, Fluge G. Resting energy expenditure and lung disease in cystic fibrosis. J Cystic Fibros 2002; 1: 131-136.
38. Simon MISS, Drehmer M, Menna -Barreto SS. Associação entre o estado nutricional e a ingestão dietética em pacientes com fibrose cística. J Bras Pneumol 2009; 35 (10): 966-972.
39. Olveira C, Olveira G, Dorado A. Energy expenditure in adult subjects with cystic fibrosis (CF): agreement between indirect calorimetry and different formulas estimates. Arch Bronconeumol 2007; 43: 366-372.
40. Shepherd RW, Greer RM, McNaughton AS. Energy expenditure and the body cell mass in cystic fibrosis. Nutrition 2001; 17: 22-5.
41. National Research Council (US). Subcommitee on the Tenth Edition of the RDAs; National Institutes of Health (US); National Research Council (US). Committee on Dietary Allowances. Recommended dietary allowances. Washington: National Academy Press; 1989.
42. Barbosa E. Nutrição. In: Ludwing Neto N. Fibrose Cistica. Enfoque Multidisciplinar. Secretaria de Estado de Saúde. Florianópolis; 2008.
43. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Clinical practice guidelines on growth and nutrition subcommittee; Ad Hoc Working Group. Evidence-based practise recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: result of a systematic review. J Am Diet Assoc 2008; 108: 832-839.
44. Steinkamp G, Wiedemann B. Relation between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. 2002; 57: 596-601.
45. Chaves CRMC, Britto JAA, Oliveira CQ, Gomes MM, Cunha ALP. Associação entre medidas do estado nutricional e a função pulmonar de crianças e adolescentes com fibrose cística. J Bras Pneumol 2009; 35 (5).
46. Konstan M W, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003; 142: 624-30.
47. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five-tofourteen- year period. Am J Dis Child. 1958; 96 (1): 6-15.
48. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth:National Center for Health Statistics percentiles. Am J Clin Nutr 1979: 32: 607-29.
49. Adde FV, Rodrigues JC, Cardoso AL: Seguimento nutricional de pacientes com fibrose cística: papel do aconselhamento nutricional. J Pediatr 2004; 80: 475-82.
50. Morlin C, Gomes LS, Morsoletto RHC, Pereira LC. Perfil nutricional dos pacientes atendidos no ambulatório de fibrose cística de um hospital público de Uberlândia-Minas Gerais. Rev Bras Nutr Clin 2006; 21 (1): 12-6.
51. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijermen HGM, Robberecht E et al. Nutrition in patients with cystic fibrosis: a european consensus. J Cystic Fibros 2002; 1: 51-75.
52. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Ped Gastroent Nutr 2002; 35 (3): 246-259.
53. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-forage, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization, 2006.
54. Pinto ICS, Silva CP, Britto MCA. Perfil nutricional, clínico e sócio-econômico de pacientes com fibrose cística atendidos em um centro de referência no nordeste do Brasil. J Bras Pneumol 2009: 35 (2).
55. Narang A, Maguire A, Nunn J, Bush A. Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Arch Dis Child 2003; 88 (8): 702-707.
56. Roth DPT, Abreu SFZ. Cystic fibrosis in adults: diagnostic and therapeutic aspects. J Bras Pneumol 2008; 34 (2): 107-117.
57. Marine J. Antibióticos por via inalatória - uma opção para prevenção e tratamento das pneumonias. Pulmão 2009; 2: 64-67.
58. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354 (3): 229-40.
59. Karl P, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J et al. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2004; 169: 719-725.
60. Jones AP, Wallins C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010; (3).
61. Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ et al. A two-year randomized, placebocontrolled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr 2001; 139 (6): 813-20.
62. Konstan MW, Wagener JS, Pasta DJ. Pulmozyme (Dornase alfa) use is associated with a slower rate of lung function decline in patients with cystic fibrosis. Pulmonol Suppl 2006; 29: 337.
63. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125 (1): 1-39.
64. Konstan MW, Davis PB. Pharmacological approaches for the discovery and development of new anti- inflammatory agents for the treatment of cystic fibrosis. Advanced Drug Delivery Reviews 2002; 54 (11): 1409-1423.
65. Hilliard T, Balfour-Lynn I. Anti-Inflammatory Agents. Prog Respir Res 2006; 34: 187-94.
66. Noone PG, Knowles MR. Standard therapy of cystic fibrosis lung disease. In: Yankaskas JR, Knowles MR, editors. Cystic fibrosis in adults. Philadelphia: Lippincott Williams & Wilkins; 1999, pp. 145-73.
67. Dezateux C, Walters S, Balfour-Lynn I. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000; (2).
68. Fagundes EDT, Roquete MLV, Penna FJ, Reis FJC, Goulart EMA, Duque CG. Fatores de risco da hepatopatia na fibrose cística. J Pediatrics 2005; 81 (6): 478-84.
69. Elphick HE, Mallory G. Oxygen therapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2009; (1).
70. British Thoracic Society (BTS) Guidelines. Clinical component for the home oxygen service in England and Wales; 2006.
71. Gomide LB, Silva CS, Matheus JPC, Torres LAGM. Atuação da fisioterapia respiratória em pacientes com fibrose cística:uma revisão da literatura. Arq Cienc Saude 2007; 14 (4): 227-233.
72. Myers LB, Horn SA. Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006; 11 (6): 915-926.
73. Veronezi J, Scortegagna D. Adherence to treatment in patients with cystic fibrosis. J Bras Pneumol 2009; 35 (3): 290-292.
74. Clinical Guidelines: Care of children with cystic fibrosis. Royal Brompton Hospital & Harefield NHS Trust. United Kingdom, 2011. [Acesso 2011 fev 02] Disponível em: www.rbht.nhs.uk/childrencf
75. Diretrizes Brasileiras para Terapia Nutricional Enteral. Projeto: Diretrizes. Sociedade Brasileira de Nutrição Parenteral e Enteral. Terapia Nutricional em Fibrose Cistica. São Paulo, 2009.
76. Rhodes B, Nash EF, Tullis E, Pencharz PB, Brotherwoo M, Dupuis A, et al. Prevalence of dyslipidemia in adults with cystic fibrosis. J Cystic Fibros 2010; 9 (1): 24-28.
77. IOM (Institute of Medicine). DRI- Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington (DC): National Academy Press, 2005.